WHAT ARE PUBERTY BLOCKERS?
Puberty blockers are medicines that temporarily pause puberty. Known medically as GnRH agonists, they have been used for decades, since the 1980s, to treat children who begin puberty unusually early, and in gender care they are used to pause the development of unwanted physical changes and give a young person time. Their effect works as a pause: medical sources describe the body's own puberty resuming when the medication is stopped.
They are considered only once puberty has begun, after a careful assessment, and, for minors, with parental consent. They are a separate thing from gender-affirming hormones, and their use in transgender youth is uncommon.
Because these medicines are widely discussed but often misunderstood, it helps to start with the basics: what they are, how they work, what they are used for, whether their effect is reversible, and who they are for. This page gives the plain-language picture and links to more detailed pages on safety and timing. It uses "puberty-pausing medication" for the treatment after the first mention; you may also see it called puberty blockers or puberty suppression, which mean the same thing.
CONTENT NOTE
This is general information, not personal medical advice. Whether this medication is appropriate for a particular young person is a decision for that young person, their family, and their qualified healthcare providers, and in nearly all cases minors cannot receive it without parental consent. If you are in immediate danger, call 911; for support any time, call or text 988.
-
They pause puberty. Puberty-pausing medication temporarily halts the physical changes of puberty.
-
They're not new. The same medicines have been used since the 1980s to treat children who start puberty too early.
-
The effect is a pause. Medical sources describe puberty resuming once the medication is stopped.
-
They're not hormones. Puberty-pausing medication is a separate, earlier step from gender-affirming hormones.
-
Their use in youth is uncommon. Fewer than 0.1% of US adolescents in a large study received puberty-pausing medication or hormones.
KEY TAKEAWAYS
-
They pause puberty. Puberty-pausing medication temporarily halts the physical changes of puberty.
-
They're not new. The same medicines have been used since the 1980s to treat children who start puberty too early.
-
The effect is a pause. Medical sources describe puberty resuming once the medication is stopped.
-
They're not hormones. Puberty-pausing medication is a separate, earlier step from gender-affirming hormones.
-
Their use in youth is uncommon. Fewer than 0.1% of US adolescents in a large study received puberty-pausing medication or hormones.
KEY TAKEAWAYS
WHAT PUBERTY-PAUSING MEDICATION IS
Puberty-pausing medication is a group of medicines called GnRH agonists that temporarily switch off the hormone signals that drive puberty.
Puberty begins when the brain signals the body to produce more sex hormones. These medicines, as described in the pharmacology reference StatPearls (NCBI), work on that signaling pathway to pause the production of those hormones, which pauses the physical development they cause.
When the medication is stopped, the signals resume and so does puberty. It is a pause button, not a permanent change to the body's own system. For a deeper look at how the medicines work, see what GnRH agonists are.
WHAT THEY ARE USED FOR
Puberty-pausing medication has two main uses, and the gender-care use grew out of decades of experience with the first. According to the American Academy of Pediatrics, these medicines have been used since the 1980s to delay puberty in children with central precocious puberty (puberty that starts unusually early), and the same reversible treatments can be used in adolescents experiencing gender dysphoria to prevent the development of unwanted secondary sex characteristics and provide time to explore gender identity and define goals.
Sources: American Academy of Pediatrics (2018); Mayo Clinic.
HOW ARE THEY GIVEN?
The medication is given either as an injection or as a small implant, depending on the option chosen with the care team.
Common forms include an injection given every few months or a thin implant placed under the skin of the upper arm that lasts about a year.
Different brand names correspond to the same class of medicine. For the specifics, see our pages on puberty blocker brand names and leuprolide versus histrelin.
IS THE EFFECT REVERSIBLE?
The medication's direct action, pausing puberty, is described as reversible: when it is stopped, the body's own puberty resumes.
As Mayo Clinic explains, when a person stops taking these medicines, puberty starts again. That is what medical bodies mean when they describe the treatment as reversible.
The honest caveat is that some longer-term questions, such as effects on bone density during treatment, are monitored and still being studied, which is why care teams track them closely. We cover this in detail on our pages on whether puberty blockers are reversible and puberty blocker side effects.
WHO ARE THEY FOR?
In gender care, puberty-pausing medication is considered only for adolescents who have begun puberty, after assessment, and its use is uncommon.
It is not used before puberty begins, and it is considered from the early stages of puberty (around Tanner stage 2), after a careful evaluation and, for minors, with parental consent.
For the timing, see what age you can start puberty blockers and Tanner stages. As for how common it is, a 2025 study in JAMA Pediatrics analyzing more than 5 million US adolescents found that fewer than 0.1% were transgender or gender-diverse and received puberty-pausing medication or hormones, and that no patient under age 12 received hormones. It is also a separate, earlier step from hormones, not the same decision.
ARE THEY SAFE?
Major US medical organizations regard supportive care, including puberty-pausing medication used appropriately, as evidence-based, and the medicines have a long track record, though care teams monitor for specific effects.
The medicines have been used for decades and are given under specialist supervision with monitoring of things like bone health. There is genuine scientific discussion about the certainty of some long-term evidence, which concerns how strong the evidence is rather than a finding of harm, and independent reviews have examined it.
We cover the full safety picture, including that discussion, on our pages on whether puberty blockers are safe and long-term effects. For how this fits into the wider landscape of care, see what gender-affirming care is.